Search Results - "Lim, D.W."

4.1 Genetically engineered elastin-like polypeptides for cartilage tissue regeneration by Setton, L.A, Nettles, D.L, Lim, D.W, Guilak, F, Chilkoti, A

Get full text

Writing current reduction and total set resistance analysis in PRAM by Jeong, C.W., Kang, D.H., Ha, D.W., Song, Y.J., Oh, J.H., Kong, J.H., Yoo, J.H., Park, J.H., Ryoo, K.C., Lim, D.W., Park, S.S., Kim, J.I., Oh, Y.T., Kim, J.S., Shin, J.M., Park, Jaehyun, Fai, Y., Koh, G.H., Jeong, G.T., Jeong, H.S., Kim, Kinam

“…We evaluated the limit of scaling bottom electrode contact (BEC) heater size and high resistivity heater to reduce writing current. It was found that the…”
Get full text

911P Post-radiotherapy (RT) Epstein-Barr virus (EBV) DNA dynamics identifies optimal timepoint for stratification of high-risk nasopharyngeal carcinoma (NPC) by Tan, J.S.H., Neo, J., Ong, E.H.W., Chow, W.M., Fong, K.W., Soong, Y.L., Sin, S.Y., Tan, D.S.W., Ang, M-K., Tan, S.H., Lim, D.W-T., Chua, M.L.K.

Get full text

227MO Characterization of minimal residual disease (MRD) post-radiotherapy (RT) in nasopharyngeal carcinoma (NPC) patients identifies a favorable subgroup with low risk of relapse by Neo, J., Ong, E., Sim, A., Miao, J.J., Wee, J.T.S., Fong, K.W., Soong, Y.L., Sin, S.Y., Tan, D.S.W., Lim, D.W-T., Ang, M-K., Chua, M.L.K.

Get full text

355O Artificial intelligence-powered spatial analysis of tumor microenvironment (TME) in nasopharyngeal carcinoma (NPC) patients treated with immune checkpoint inhibitors (ICI) by Keam, B., Lim, D.W-T., Ock, C-Y., Lee, T., Oum, C., Kao, H-F., Yeong, J., Goh, B.C., Tan, S.H., Hui, E.P., Jung, H.A., Park, K-U., Cho, S-H., Lee, K-W., Chan, A.T.C., Ma, B.

Get full text

596P Repotrectinib in patients (pts) from Asia and China with ROS1 fusion-positive (ROS1+) non-small cell lung cancer (NSCLC): Results from the phase I/II TRIDENT-1 trial by Lu, S., Hu, X., Kim, S-W., Goto, K., Yang, N., Soo, R.A., Fang, J., Yao, W., Lee, K.H., Lim, D.W-T., Kato, T., Tamiya, M., Wu, J., Zhang, Y., Zhou, J., Ades, F., Hua, J., Wang, P.T., Cho, B.C.

Get full text

354O A phase Ib/II study of nanatinostat (Nstat) plus valganciclovir (VGCV) in EBV+ solid tumors and with pembrolizumab (PEM) in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC) by Colevas, A.D., Siu, L., Lim, D.W-T., Gao, B., Voon, P-J., Khan, S., Eng, L., Ahn, M-J., Lee, V., Wang, H.M., Yang, M-H., Bowles, D., Ferrarotto, R., Elguindy, A., Katkov, A., McGovern, K., Ma, B.

Get full text

1046P Phase I/II open-label study on an anti-GPC3 T cell engager, SAR444200, in patients with advanced solid tumors: Preliminary dose escalation results by Yong Hong, J., Ryoo, B-Y., Chenard-Poirier, M., Almhanna, K., Lim, D.W-T., Samol, J., Abbadessa, G., Meng, R., Masciari, S., Kefsi, A., Zhang, Y., Guillemin-Paveau, H., Pasquier, B., Lepine, L., Dumbrava, E.E.

Get full text

1372P Repotrectinib in patients (pts) with NTRK fusion-positive (NTRK+) advanced solid tumors, including NSCLC: Update from the phase I/II TRIDENT-1 trial by Solomon, B.J., Drilon, A., Lin, J.J., Bazhenova, L., Goto, K., De Langen, J., Kim, D-W., Wolf, J., Springfeld, C., Popat, S., Lim, D.W-T., Baik, C.S., Hervieu, A., Moreno Garcia, V., Yang, N., Thamake, S., Ades, F., Trone, D., Besse, B.

Get full text

266O Combination ipilimumab and nivolumab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Updated efficacy and safety analysis of NCT03097939 by Kao, H-F., Ang, M-K., Ng, Q.S., Tan, D.S.W., Tan, W., Rajasekaran, T., Jain, A., Liao, B-C., Tan, S.H., Tan, E-H., Iyer, N.G., Chua, M.L.K., Hong, R-L., Lim, D.W-T.

Get full text

1293P IMpower150: Updated efficacy analysis in patients with EGFR mutations by Reck, M., Mok, T., Socinski, M.A., Jotte, R.M., Lim, D.W-T., Cappuzzo, F., Orlandi, F.J., Stroyakovskiy, D., Nogami, N., Rodriguez-Abreu, D., Moro-Sibilot, D., Thomas, C.A., Barlesi, F., Finley, G., Shankar, G., Yu, W., Merritt, D., Nishio, M.

Get full text

Healthcare workers as ‘canaries’ for acute respiratory infections and pathogens during the COVID-19 pandemic by Lim, D.W., Htun, H.L., Wang, Y., Li, A.L., Kyaw, W.M., Lee, L.T., Chow, A.

Get full text

322P Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (SCC) in Singapore by Fong, P.Y., Acharyya, S., Lim, D.W., Tan, E.-H., Ng, Q.S., Tan, D., Ang, M.K.

Get full text

Full Integration of Highly Manufacturable 512Mb PRAM based on 90nm Technology by Oh, J.H., Park, J.H., Lim, Y.S., Lim, H.S., Oh, Y.T., Kim, J.S., Shin, J.M., Song, Y.J., Ryoo, K.C., Lim, D.W., Park, S.S., Kim, J.I., Kim, J.H., Yu, J., Yeung, F., Jeong, C.W., Kong, J.H., Kang, D.H., Koh, G.H., Jeong, G.T., Jeong, H.S., Kinam Kim

“…Fully functional 512Mb PRAM with 0.047mum 2 (5.8F 2 ) cell size was successfully fabricated using 90nm diode technology in which the authors developed novel…”
Get full text

230P Clinicopathologic and molecular features of STK11-mutated NSCLC by Saw, P.L.S., Pang, M., Tan, G.S., Sim, N.L., Patteri, C., Lai, G., Tan, A., Chan, J., Tan, W.L., Ng, Q.S., Ang, M-K., Lim, D.W-T., Lim, T.K.H., Skanderup, A., Tan, D.S.W.

Get full text

156P A phase Ib/II study of nanatinostat (Nstat) plus valganciclovir (VGCV) in advanced Epstein-Barr virus positive (EBV+) solid tumors and with pembrolizumab (PEM) in recurrent/metastatic nasopharyngeal carcinoma (RM-NPC) by Colevas, A.D., Siu, L.L., Lim, D.W-T., Gao, B., Khan, S.A., Eng, L., Voon, P.J., Ahn, M-J., Elguindy, A., Katkov, A., Rojkjaer, L., Katz, Y., Ma, B.B.Y.

Get full text

85O Low-pass whole genome sequencing (lpWGS) to quantify circulating tumor DNA (ctDNA) burden as a pharmacodynamic response biomarker in patients on early phase trials by Tan, A.C., Guo, Y.A., Rahman, C.R., Tan, T.J.Y., Saw, P.L.S., Lam, J., Tai, D., Lim, D.W-T., Chang, E.W.Y., Chan, J., Tan, W.C., Tan, S., Boey, M., Carolyn, C., Carrie, H.C., Yeo, J.C., Tan, I., Ng, M.C.H., Tan, D.S.W., Skanderup, A.

Get full text

IMpower150: An exploratory analysis of efficacy outcomes in patients with EGFR mutations by Reck, M., Jotte, R., Mok, T.S.K., Lim, D.W.-T., Cappuzzo, F., Orlandi, F., Stroyakovskiy, D., Nogami, N., Rodríguez-Abreu, D., Moro-Sibilot, D., Thomas, C.A., Barlesi, F., Finley, G., Nishio, M., Lee, A., Shankar, G., Yu, W., Socinski, M.A.

Get full text

Clinicopathological characteristics and outcome of advanced ROS1-positive non-small cell lung cancer in Asian patients by Kho, C.Y.X., Lim, D.W.-T., Tan, D.S.W., Tan, W.L., Rajasekaran, T., Jain, A., Toh, C.K., Ang, M.-K., Tan, E.H., Ng, Q.S.

Get full text

IMpower150: An exploratory analysis of efficacy outcomes in patients with EGFR mutations by Mok, T.S.K., Socinski, M.A., Reck, M., Jotte, R.M., Lim, D.W.-T., Cappuzzo, F., Orlandi, F.J., Stroyakovskiy, D., Nogami, N., Rodríguez-Abreu, D., Moro-Siblot, D., Thomas, C.A., Barlesi, F., Finley, G., Lee, A., Shankar, G., Yu, W., Kowanetz, M., Lin, W., Nishio, M.

Get full text